Longboard Pharmaceuticals Inc (LBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2020 | 09-2020 | 06-2020 | 03-2020 | |
Operating Expenses | 10,109 | 2,550 | 1,567 | 174 |
Operating Income | -10,109 | -2,550 | -1,567 | -174 |
Pre-tax Income | -10,109 | -2,550 | -1,567 | -174 |
Net Income Continuous | -10,109 | -2,550 | -1,567 | -174 |
Net Income | $-10,109 | $-2,550 | $-1,567 | $-174 |
EPS Basic Total Ops | -2.66 | -0.66 | -0.41 | -0.05 |
EPS Basic Continuous Ops | -2.66 | -0.66 | -0.41 | -0.05 |
EPS Diluted Total Ops | -2.66 | -0.66 | -0.41 | -0.05 |
EPS Diluted Continuous Ops | -2.66 | -0.66 | -0.41 | -0.05 |
EBITDA(a) | $-10,109 | $-2,550 | $-1,567 | $-174 |